Long-term evolution of antigen repertoires among carried meningococci

Proceedings of the Royal Society B: Biological Sciences

Volumn 277, Issue 1688, 2010, Pages 1635-1641

  Buckee, Caroline O ^a,b   Gupta, Sunetra ^a   Kriz, Paula ^c   Maiden, Martin C J ^a   Jolley, Keith A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b SANTA FE INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Bacterial population structure; Neisseria meningitidis; Network

Indexed keywords

ALLELE; ANTIGEN; BACTERIUM; COMMENSAL; EVOLUTIONARY BIOLOGY; GENE EXPRESSION; LONG-TERM CHANGE; MENINGITIS; NUMERICAL MODEL; PATHOGEN; POPULATION STRUCTURE; RECOMBINATION; VACCINE;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS;

EID: 77953483090     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2009.2033     Document Type: Conference Paper

References (28)

1. Bjune, G., Closs, O., Froholm, L. O., Gronnesby, J. K., Hoiby, E. A. & Nokleby, H. 1991 Design of clinical trials with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway. NIPH Ann. 14, 81-91 (discussion 91-93).
2. Buckee, C. O., Koelle, K., Mustard, M. J. & Gupta, S. 2004 The effects of host contact network structure on pathogen diversity and strain structure. Proc. Natl Acad. Sci. USA 101, 10 839-10 844. (doi:10.1073/pnas. 0402000101) (Pubitemid 38955829)
3. Buckee, C. O., Jolley, K. A., Recker, M., Penman, B., Kriz, P., Gupta, S. & Maiden, M. C. 2008 Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis. Proc. Natl Acad. Sci. USA 105, 15 082-15 087. (doi:10.1073/pnas.0712019105)
4. Caugant, D. A. & Maiden, M. C.J. 2009 Meningococcal carriage and disease-population biology and evolution. Vaccine 27, B64-B70. (doi:10.1016/j.vaccine.2009.04. 061)
5. Feil, E. J., Li, B. C., Aanensen, D. M., Hanage, W. P. & Spratt, B. G. 2004 eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186, 1518-1530. (doi:10.1128/JB.186.5. 1518-1530.2004)
6. Gog, J. R. & Grenfell, B. T. 2002 Dynamics and selection of many-strain pathogens. Proc. Natl Acad. Sci. USA 99, 17 209-17 214. (doi:10.1073/pnas.252512799)
7. Gog, J. R. & Swinton, J. 2002 A status-based approach to multiple strain dynamics. J. Math. Biol. 44, 169-184. (doi:10.1007/s002850100120) (Pubitemid 44200138)
8. Gomes, M. G., Medley, G. F. & Nokes, D. J. 2002 On the determinants of population structure in antigenically diverse pathogens. Proc. R. Soc. Lond. B 269, 227-233. (doi:10.1098/rspb.2001.1869)
9. Gupta, S., Maiden, M. C., Feavers, I. M., Nee, S., May, R. M. & Anderson, R. M. 1996 The maintenance of strain structure in populations of recombining infectious agents. Nat. Med. 2, 437-442. (doi:10.1038/nm0496-437) (Pubitemid 26191916)
10. Harrison, L. H., Jolley, K. A., Shutt, K. A., Marsh, J. W., O'Leary, M., Sanza, L. T. & Maiden, M. C. 2006 Antigenic shift and increased incidence of meningococcal disease. J Infect. Dis. 193, 1266-1274. (doi:10.1086/ 501371)
11. Harrison, L. H., Trotter, C. L. & Ramsey, M. E. 2009 Global epidemiology of meningococcal disease. Vaccine 27, B51-B53. (doi:10.1016/j. vaccine.2009.04.063)
12. Hedrick, P. W. & Thomson, G. 1986 A two-locus neutrality test: applications to humans, E. coli and lodgepole pine. Genetics 112, 135-156. (Pubitemid 16160162)
13. Hosking, J. et al. 2007 Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens. Clin. Vaccine Immunol. 14, 1393-1399. (doi: 10.1128/CVI.00167-07) (Pubitemid 350304030)
14. Jodar, L., Feavers, I. M., Salisbury, D. & Granoff, D. M. 2002 Development of vaccines against meningococcal disease. Lancet 359, 1499-1508. (doi:10.1016/S01406736(02)08416-7) (Pubitemid 34457772)
15. Jolley, K. A., Kalmusova, J., Feil, E. J., Gupta, S., Musilek, M., Kriz, P. & Maiden, M. C. 2000 Carried meningococci in the Czech Republic: a diverse recombining population. J. Clin. Microbiol. 38, 4492-4498. (Pubitemid 32244539)
16. Jolley, K. A., Wilson, D. J., Kriz, P., Mcvean, G. & Maiden, M. C. 2005 The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis. Mol. Biol. Evol. 22, 562-569. (doi:10.1093/molbev/msi041) (Pubitemid 40299505)
17. 97-conjugated serogroup C meningococcal polysaccharide vaccine. Immunology 127, 134-143. (doi: 10.1111/j.1365-2567. 2008.02934.x)
18. Krizova, P., Musilek, M. & Kalmusova, J. 1997 Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37. Cent. Eur. J. Public Health 5, 214-218. (Pubitemid 28137257)
19. McGuinness, B. T., Lambden, P. R. & Heckels, J. E. 1993 Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol. Microbiol. 7, 505-514. (doi:10.1111/j. 1365-2958.1993. tb01141.x)
20. O'Hallahan, J., Lennon, D. & Oster, P. 2004 The strategy to control New Zealand's epidemic of group B meningococcal disease. Pediatr. Infect. Dis. J. 23, S293-S298. (Pubitemid 44544512)
21. Russell, J. E., Jolley, K. A., Feavers, I. M., Maiden, M. C. & Suker, J. 2004 PorA variable regions of Neisseria meningitidis. Emerg. Infect. Dis. 10, 674-678.
22. Sierra, G. V. et al. 1991 Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14, 195-207 (discussion 208-210).
23. Smith, J. M., Smith, N. H., O'Rourke, M. & Spratt, B. G. 1993 How clonal are bacteria? Proc. Natl Acad. Sci. USA 90, 4384-4388. (doi:10.1073/pnas.90. 10.4384) (Pubitemid 23148908)
24. Thompson, E. A., Feavers, I. M. & Maiden, M. C. 2003 Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 149, 1849-1858. (doi:10.1099/mic.0.26131-0)
25. Tsang, R. S., Law, D. K., Henderson, A. M., Blake, M. L. & Stoltz, J. 2006 Increase in serogroup C meningococcal disease in Canada is associated with antigenic changes in the protein antigens of the ET-15 clone of Neisseria meningitidis. J. Infect. Dis. 194, 1791-1792 (author reply 1792-1793). (doi:10.1086/509515) (Pubitemid 44902013)
26. Urwin, R., Russell, J. E., Thompson, E. A., Holmes, E. C., Feavers, I. M. & Maiden, M. C. 2004 Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect. Immun. 72, 5955-5962. (doi: 10.1128/IAI.72.10.59555962.2004) (Pubitemid 39303710)
27. Weber, M. V., Claus, H., Maiden, M. C., Frosch, M. & Vogel, U. 2006 Genetic mechanisms for loss of encapsulation in polysialyltransferase-gene- positive meningococci isolated from healthy carriers. Inu J. Med. Microbiol. 296, 475-484. (doi:10.1016/j.ijmm.2006.05.004) (Pubitemid 44604356)
28. Yazdankhah, S. P. et al. 2004 Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J. Clin. Microbiol. 42, 5146-5153. (doi:10.1128/JCM.42.11.5146-5153.2004)